{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T00:12:17Z","timestamp":1793578337184,"version":"4.5.0"},"reference-count":55,"publisher":"Oxford University Press (OUP)","issue":"2","license":[{"start":{"date-parts":[[2025,2,14]],"date-time":"2025-02-14T00:00:00Z","timestamp":1739491200000},"content-version":"vor","delay-in-days":13,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82070356"],"award-info":[{"award-number":["82070356"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82270337"],"award-info":[{"award-number":["82270337"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Key Project of Hunan Provincial Science and Technology Innovation","award":["2020SK1013"],"award-info":[{"award-number":["2020SK1013"]}]},{"DOI":"10.13039\/501100004735","name":"Hunan Provincial Natural Science Foundation of China","doi-asserted-by":"crossref","award":["2024JJ6593"],"award-info":[{"award-number":["2024JJ6593"]}],"id":[{"id":"10.13039\/501100004735","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,2,5]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Aims<\/jats:title>\n                    <jats:p>Atrial fibrillation and atrial flutter (AF\/AFL) are critical global health concerns, yet studies on burden trends and sex differences remain limited. This study aims to investigate the global burden trends of AF\/AFL, with an in-depth analysis of differences between sexes and future trends, in order to address gaps in the current research field.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods and results<\/jats:title>\n                    <jats:p>This study utilized data from the Global Burden of Disease 2021 study, applying methods such as age-period-cohort analysis and joinpoint regression models to evaluate trends and sex differences in the incidence, prevalence, mortality, and disability-adjusted life years (DALYs) of AF\/AFL among individuals aged 30 and above from 1990 to 2021, and employed Bayesian age-period-cohort (BAPC) analysis to predict future trends from 2022 to 2046. In 2021, AF\/AFL affected around 52.6 million people globally, with significant increases in cases, deaths, and DALYs since 1990. While the age-standardized prevalence rate (ASPR) remained stable, the age-standardized incidence rate (ASIR) slightly declined, and the age-standardized mortality rate (ASMR) increased. Moreover, there were significant differences in the disease burden between male and female patients. Males had higher prevalence and DALYs, with older age contributing to higher rates. Key risk factors included high systolic blood pressure, body mass index (BMI), and alcohol use, with female patients exhibiting a higher age-standardized rates associated with elevated BMI compared with their male counterparts. Bayesian age-period-cohort predicted stable ASPR and ASIR in males but rising rates in females, with ASMR expected to decline for both sexes.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>The global burden of AF\/AFL is rising, particularly among women, and in low-socio-demographic index regions. This underscores the urgent need for targeted prevention strategies and optimized management of modifiable risk factors, with a specific focus on these vulnerable groups.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/europace\/euaf027","type":"journal-article","created":{"date-parts":[[2025,2,7]],"date-time":"2025-02-07T23:29:47Z","timestamp":1738970987000},"source":"Crossref","is-referenced-by-count":102,"title":["Global, regional, and national burden of atrial fibrillation and atrial flutter from 1990 to 2021: sex differences and global burden projections to 2046\u2014a systematic analysis of the Global Burden of Disease Study 2021"],"prefix":"10.1093","volume":"27","author":[{"given":"Siyuan","family":"Tan","sequence":"first","affiliation":[{"name":"Department of Cardiovascular Medicine, The Second Xiangya Hospital, Central South University , No. 139, Renmin Middle Road, Changsha, Hunan 410011 ,","place":["China"]},{"name":"Modern Cardiovascular Disease Clinical Technology Research Center of Hunan Province , No. 139, Renmin Middle Road, Changsha, Hunan 410011 ,","place":["China"]},{"name":"Cardiovascular Disease Research Center of Hunan Province , No. 139, Renmin Middle Road, Changsha, Hunan 410011 ,","place":["China"]},{"name":"Research Institute of Blood Lipid and Atherosclerosis, The Second Xiangya Hospital, Central South University , No. 139, Renmin Middle Road, Changsha, Hunan 410011 ,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-8547-9491","authenticated-orcid":false,"given":"Jiabao","family":"Zhou","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, The Second Xiangya Hospital, Central South University , No. 139, Renmin Middle Road, Changsha, Hunan 410011 ,","place":["China"]},{"name":"Modern Cardiovascular Disease Clinical Technology Research Center of Hunan Province , No. 139, Renmin Middle Road, Changsha, Hunan 410011 ,","place":["China"]},{"name":"Cardiovascular Disease Research Center of Hunan Province , No. 139, Renmin Middle Road, Changsha, Hunan 410011 ,","place":["China"]},{"name":"Research Institute of Blood Lipid and Atherosclerosis, The Second Xiangya Hospital, Central South University , No. 139, Renmin Middle Road, Changsha, Hunan 410011 ,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-8310-5670","authenticated-orcid":false,"given":"Tevit","family":"Veang","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, The Second Xiangya Hospital, Central South University , No. 139, Renmin Middle Road, Changsha, Hunan 410011 ,","place":["China"]},{"name":"Modern Cardiovascular Disease Clinical Technology Research Center of Hunan Province , No. 139, Renmin Middle Road, Changsha, Hunan 410011 ,","place":["China"]},{"name":"Cardiovascular Disease Research Center of Hunan Province , No. 139, Renmin Middle Road, Changsha, Hunan 410011 ,","place":["China"]},{"name":"Research Institute of Blood Lipid and Atherosclerosis, The Second Xiangya Hospital, Central South University , No. 139, Renmin Middle Road, Changsha, Hunan 410011 ,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiuzhen","family":"Lin","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, The Second Xiangya Hospital, Central South University , No. 139, Renmin Middle Road, Changsha, Hunan 410011 ,","place":["China"]},{"name":"Modern Cardiovascular Disease Clinical Technology Research Center of Hunan Province , No. 139, Renmin Middle Road, Changsha, Hunan 410011 ,","place":["China"]},{"name":"Cardiovascular Disease Research Center of Hunan Province , No. 139, Renmin Middle Road, Changsha, Hunan 410011 ,","place":["China"]},{"name":"Research Institute of Blood Lipid and Atherosclerosis, The Second Xiangya Hospital, Central South University , No. 139, Renmin Middle Road, Changsha, Hunan 410011 ,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5213-2668","authenticated-orcid":false,"given":"Qiming","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, The Second Xiangya Hospital, Central South University , No. 139, Renmin Middle Road, Changsha, Hunan 410011 ,","place":["China"]},{"name":"Modern Cardiovascular Disease Clinical Technology Research Center of Hunan Province , No. 139, Renmin Middle Road, Changsha, Hunan 410011 ,","place":["China"]},{"name":"Cardiovascular Disease Research Center of Hunan Province , No. 139, Renmin Middle Road, Changsha, Hunan 410011 ,","place":["China"]},{"name":"Research Institute of Blood Lipid and Atherosclerosis, The Second Xiangya Hospital, Central South University , No. 139, Renmin Middle Road, Changsha, Hunan 410011 ,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2025,2,14]]},"reference":[{"key":"2025030423483480300_euaf027-B1","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1038\/s41572-022-00347-9","article-title":"Atrial fibrillation","volume":"8","author":"Brundel","year":"2022","journal-title":"Nat Rev Dis Primers"},{"key":"2025030423483480300_euaf027-B2","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1161\/CIRCULATIONAHA.123.067544","article-title":"Atrial fibrillation: why are we hiding reality?","volume":"149","author":"Reiffel","year":"2024","journal-title":"Circulation"},{"key":"2025030423483480300_euaf027-B3","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1161\/CIR.0000000000001193","article-title":"2023 ACC\/AHA\/ACCP\/HRS guideline for the diagnosis and management of atrial fibrillation: a report of the American College of Cardiology\/American Heart Association joint Committee on Clinical Practice Guidelines","volume":"149","author":"Joglar","year":"2024","journal-title":"Circulation"},{"key":"2025030423483480300_euaf027-B4","doi-asserted-by":"crossref","first-page":"Itc33","DOI":"10.7326\/AITC201703070","article-title":"Atrial fibrillation","volume":"166","author":"Zimetbaum","year":"2017","journal-title":"Ann Intern Med"},{"key":"2025030423483480300_euaf027-B5","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1146\/annurev-physiol-031720-085307","article-title":"Dynamics of atrial fibrillation mechanisms and comorbidities","volume":"83","author":"Heijman","year":"2021","journal-title":"Annu Rev Physiol"},{"key":"2025030423483480300_euaf027-B6","doi-asserted-by":"crossref","first-page":"2218","DOI":"10.1001\/jama.2020.23700","article-title":"Atrial fibrillation","volume":"325","author":"Baman","year":"2021","journal-title":"JAMA"},{"key":"2025030423483480300_euaf027-B7","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1038\/s41569-019-0166-5","article-title":"Postoperative atrial fibrillation: mechanisms, manifestations and management","volume":"16","author":"Dobrev","year":"2019","journal-title":"Nat Rev Cardiol"},{"key":"2025030423483480300_euaf027-B8","doi-asserted-by":"crossref","first-page":"e38","DOI":"10.1056\/NEJMp2212939","article-title":"Atrial fibrillation\u2014what is it and how is it treated?","volume":"387","author":"Antman","year":"2022","journal-title":"N Engl J Med"},{"key":"2025030423483480300_euaf027-B9","doi-asserted-by":"crossref","first-page":"35","DOI":"10.3949\/ccjm.84a.16016","article-title":"Fall risk and anticoagulation for atrial fibrillation in the elderly: a delicate balance","volume":"84","author":"Hagerty","year":"2017","journal-title":"Cleve Clin J Med"},{"key":"2025030423483480300_euaf027-B10","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1038\/s41569-022-00820-8","article-title":"Epidemiology and modifiable risk factors for atrial fibrillation","volume":"20","author":"Elliott","year":"2023","journal-title":"Nat Rev Cardiol"},{"key":"2025030423483480300_euaf027-B11","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.amjcard.2021.02.014","article-title":"Incidence and mortality trends of atrial fibrillation\/atrial flutter in the United States 1990 to 2017","volume":"148","author":"DeLago","year":"2021","journal-title":"Am J Cardiol"},{"key":"2025030423483480300_euaf027-B12","doi-asserted-by":"crossref","first-page":"04154","DOI":"10.7189\/jogh.13.04154","article-title":"Global, regional, and national burdens of atrial fibrillation\/flutter from 1990 to 2019: an age-period-cohort analysis using the Global Burden of Disease 2019 study","volume":"13","author":"Li","year":"2023","journal-title":"J Glob Health"},{"key":"2025030423483480300_euaf027-B13","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1093\/europace\/euac237","article-title":"Global burden of atrial fibrillation\/atrial flutter and its attributable risk factors from 1990 to 2019","volume":"25","author":"Dong","year":"2023","journal-title":"Europace"},{"key":"2025030423483480300_euaf027-B14","doi-asserted-by":"crossref","first-page":"2982","DOI":"10.1016\/j.jacc.2020.11.010","article-title":"Global burden of cardiovascular diseases and risk factors, 1990\u20132019: update from the GBD 2019 study","volume":"76","author":"Roth","year":"2020","journal-title":"J Am Coll Cardiol"},{"key":"2025030423483480300_euaf027-B15","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1161\/CIRCRESAHA.120.316340","article-title":"Epidemiology of atrial fibrillation in the 21st century: novel methods and new insights","volume":"127","author":"Kornej","year":"2020","journal-title":"Circ Res"},{"key":"2025030423483480300_euaf027-B16","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ccep.2020.10.010","article-title":"Epidemiology of atrial fibrillation: geographic\/ecological risk factors, age, sex, genetics","volume":"13","author":"Zhang","year":"2021","journal-title":"Card Electrophysiol Clin"},{"key":"2025030423483480300_euaf027-B17","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1001\/jamacardio.2022.2825","article-title":"Sex differences in atrial fibrillation risk: the VITAL rhythm study","volume":"7","author":"Siddiqi","year":"2022","journal-title":"JAMA Cardiol"},{"key":"2025030423483480300_euaf027-B18","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1055\/s-0043-1776394","article-title":"Sex as a risk factor for atrial fibrillation-related stroke","volume":"124","author":"Corica","year":"2024","journal-title":"Thromb Haemost"},{"key":"2025030423483480300_euaf027-B19","doi-asserted-by":"crossref","first-page":"2296","DOI":"10.1158\/1055-9965.EPI-14-0300","article-title":"A web tool for age-period-cohort analysis of cancer incidence and mortality rates","volume":"23","author":"Rosenberg","year":"2014","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"2025030423483480300_euaf027-B20","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1002\/(SICI)1097-0258(20000215)19:3<335::AID-SIM336>3.0.CO;2-Z","article-title":"Permutation tests for joinpoint regression with applications to cancer rates","volume":"19","author":"Kim","year":"2000","journal-title":"Stat Med"},{"key":"2025030423483480300_euaf027-B21","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1186\/s12874-020-01133-5","article-title":"An R package for an integrated evaluation of statistical approaches to cancer incidence projection","volume":"20","author":"Knoll","year":"2020","journal-title":"BMC Med Res Methodol"},{"key":"2025030423483480300_euaf027-B22","doi-asserted-by":"crossref","first-page":"euae195","DOI":"10.1093\/europace\/euae195","article-title":"Global burden of atrial fibrillation\/atrial flutter and its attributable risk factors from 1990 to 2021","volume":"26","author":"Cheng","year":"2024","journal-title":"Europace"},{"key":"2025030423483480300_euaf027-B23","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1016\/j.jacep.2021.02.021","article-title":"Sex-specific prevalence, incidence, and mortality associated with atrial fibrillation in heart failure","volume":"7","author":"Barillas-Lara","year":"2021","journal-title":"JACC Clin Electrophysiol"},{"key":"2025030423483480300_euaf027-B24","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1161\/01.CIR.98.10.946","article-title":"Impact of atrial fibrillation on the risk of death: the Framingham Heart Study","volume":"98","author":"Benjamin","year":"1998","journal-title":"Circulation"},{"key":"2025030423483480300_euaf027-B25","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/S0140-6736(14)61774-8","article-title":"50 year trends in atrial fibrillation prevalence, incidence, risk factors, and mortality in the Framingham Heart Study: a cohort study","volume":"386","author":"Schnabel","year":"2015","journal-title":"Lancet"},{"key":"2025030423483480300_euaf027-B26","doi-asserted-by":"crossref","first-page":"2133","DOI":"10.1016\/S0140-6736(24)00757-8","article-title":"Global incidence, prevalence, years lived with disability (YLDs), disability-adjusted life-years (DALYs), and healthy life expectancy (HALE) for 371 diseases and injuries in 204 countries and territories and 811 subnational locations, 1990\u20132021: a systematic analysis for the global burden of disease study 2021","volume":"403","author":"GBD 2021 Diseases and Injuries Collaborators","year":"2024","journal-title":"Lancet"},{"key":"2025030423483480300_euaf027-B27","doi-asserted-by":"crossref","first-page":"136","DOI":"10.2174\/1573403X15666181205110624","article-title":"Gender differences in atrial fibrillation: a review of epidemiology, management, and outcomes","volume":"15","author":"Westerman","year":"2019","journal-title":"Curr Cardiol Rev"},{"key":"2025030423483480300_euaf027-B28","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1093\/eurheartj\/ehad508","article-title":"Stroke risk in women with atrial fibrillation","volume":"45","author":"Buhari","year":"2024","journal-title":"Eur Heart J"},{"key":"2025030423483480300_euaf027-B29","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.1038\/s41591-019-0643-8","article-title":"Sex differences in cardiometabolic disorders","volume":"25","author":"Gerdts","year":"2019","journal-title":"Nat Med"},{"key":"2025030423483480300_euaf027-B30","doi-asserted-by":"crossref","first-page":"e072385","DOI":"10.1136\/bmj-2022-072385","article-title":"Global burden of type 2 diabetes in adolescents and young adults, 1990\u20132019: systematic analysis of the Global Burden of Disease Study 2019","volume":"379","author":"Xie","year":"2022","journal-title":"BMJ"},{"key":"2025030423483480300_euaf027-B31","doi-asserted-by":"crossref","first-page":"e750","DOI":"10.1161\/CIR.0000000000000748","article-title":"Lifestyle and risk factor modification for reduction of atrial fibrillation: a scientific statement from the American Heart Association","volume":"141","author":"Chung","year":"2020","journal-title":"Circulation"},{"key":"2025030423483480300_euaf027-B32","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1186\/s12939-016-0389-6","article-title":"Income inequality and foregone medical care in Europe during the great recession: multilevel analyses of EU-SILC surveys 2008\u20132013","volume":"15","author":"Elstad","year":"2016","journal-title":"Int J Equity Health"},{"key":"2025030423483480300_euaf027-B33","doi-asserted-by":"crossref","first-page":"e327","DOI":"10.1002\/hpm.2652","article-title":"Effects of the 2008 global financial crisis on population health","volume":"34","author":"Habibov","year":"2019","journal-title":"Int J Health Plann Manage"},{"key":"2025030423483480300_euaf027-B34","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/S0140-6736(07)61233-1","article-title":"Warfarin versus aspirin for stroke prevention in an elderly community population with atrial fibrillation (the Birmingham Atrial Fibrillation Treatment of The Aged Study, BAFTA): a randomised controlled trial","volume":"370","author":"Mant","year":"2007","journal-title":"Lancet"},{"key":"2025030423483480300_euaf027-B35","doi-asserted-by":"crossref","first-page":"2836","DOI":"10.1093\/eurheartj\/ehaa055","article-title":"Integrated management of atrial fibrillation in primary care: results of the ALL-IN cluster randomized trial","volume":"41","author":"van den Dries","year":"2020","journal-title":"Eur Heart J"},{"key":"2025030423483480300_euaf027-B36","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1038\/nrcardio.2017.153","article-title":"The ABC pathway: an integrated approach to improve AF management","volume":"14","author":"Lip","year":"2017","journal-title":"Nat Rev Cardiol"},{"key":"2025030423483480300_euaf027-B37","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.1093\/eurheartj\/ehw054","article-title":"The ABC (age, biomarkers, clinical history) stroke risk score: a biomarker-based risk score for predicting stroke in atrial fibrillation","volume":"37","author":"Hijazi","year":"2016","journal-title":"Eur Heart J"},{"key":"2025030423483480300_euaf027-B38","doi-asserted-by":"crossref","first-page":"1730","DOI":"10.1093\/europace\/euac082","article-title":"Evaluation of the atrial fibrillation better care pathway in the ENGAGE AF-TIMI 48 trial","volume":"24","author":"Patel","year":"2022","journal-title":"Europace"},{"key":"2025030423483480300_euaf027-B39","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.ejim.2022.11.002","article-title":"Mobile health-technology integrated care in atrial fibrillation patients with heart failure: a report from the mAFA-II randomized clinical trial","volume":"107","author":"Guo","year":"2023","journal-title":"Eur J Intern Med"},{"key":"2025030423483480300_euaf027-B40","doi-asserted-by":"crossref","first-page":"2958","DOI":"10.1093\/eurheartj\/ehab530","article-title":"Obesity and effects of dapagliflozin on cardiovascular and renal outcomes in patients with type 2 diabetes mellitus in the DECLARE-TIMI 58 trial","volume":"43","author":"Oyama","year":"2022","journal-title":"Eur Heart J"},{"key":"2025030423483480300_euaf027-B41","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1038\/s41569-024-01017-x","article-title":"Cardiovascular disease and cancer: shared risk factors and mechanisms","volume":"21","author":"Wilcox","year":"2024","journal-title":"Nat Rev Cardiol"},{"key":"2025030423483480300_euaf027-B42","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1161\/CIRCULATIONAHA.116.025312","article-title":"Atrial fibrillation and ventricular arrhythmias: sex differences in electrophysiology, epidemiology, clinical presentation, and clinical outcomes","volume":"135","author":"Gillis","year":"2017","journal-title":"Circulation"},{"key":"2025030423483480300_euaf027-B43","doi-asserted-by":"crossref","first-page":"2594","DOI":"10.1093\/eurheartj\/ehae365","article-title":"Great debate: device-detected subclinical atrial fibrillation should be treated like clinical atrial fibrillation","volume":"45","author":"Sanders","year":"2024","journal-title":"Eur Heart J"},{"key":"2025030423483480300_euaf027-B44","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1038\/s41569-021-00561-0","article-title":"Social determinants of atrial fibrillation","volume":"18","author":"Essien","year":"2021","journal-title":"Nat Rev Cardiol"},{"key":"2025030423483480300_euaf027-B45","doi-asserted-by":"crossref","first-page":"4148","DOI":"10.1093\/eurheartj\/ehac364","article-title":"Age at menopause and risk of heart failure and atrial fibrillation: a nationwide cohort study","volume":"43","author":"Shin","year":"2022","journal-title":"Eur Heart J"},{"key":"2025030423483480300_euaf027-B46","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.jacep.2021.10.004","article-title":"Arrhythmias in pregnancy","volume":"8","author":"Tamirisa","year":"2022","journal-title":"JACC Clin Electrophysiol"},{"key":"2025030423483480300_euaf027-B47","doi-asserted-by":"crossref","first-page":"3718","DOI":"10.1093\/eurheartj\/ehae540","article-title":"CHA2DS2-VASc or a non-sex score (CHA2DS2-VA) for stroke risk prediction in atrial fibrillation: contemporary insights and clinical implications","volume":"45","author":"Lip","year":"2024","journal-title":"Eur Heart J"},{"key":"2025030423483480300_euaf027-B48","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/j.amjcard.2013.10.035","article-title":"Meta-analysis of gender differences in residual stroke risk and major bleeding in patients with nonvalvular atrial fibrillation treated with oral anticoagulants","volume":"113","author":"Pancholy","year":"2014","journal-title":"Am J Cardiol"},{"key":"2025030423483480300_euaf027-B49","doi-asserted-by":"crossref","first-page":"2913","DOI":"10.1016\/j.jacc.2016.03.581","article-title":"Aspirin instead of oral anticoagulant prescription in atrial fibrillation patients at risk for stroke","volume":"67","author":"Hsu","year":"2016","journal-title":"J Am Coll Cardiol"},{"key":"2025030423483480300_euaf027-B50","doi-asserted-by":"crossref","first-page":"euae264","DOI":"10.1093\/europace\/euae264","article-title":"Sex- and age-specific differences in the use of antiarrhythmic therapies among atrial fibrillation patients: a nationwide cohort study","volume":"26","author":"Salmela","year":"2024","journal-title":"Europace"},{"key":"2025030423483480300_euaf027-B51","doi-asserted-by":"crossref","first-page":"f72","DOI":"10.1093\/ehjcvp\/pvaa017","article-title":"Long-term persistence and adherence with non-vitamin K oral anticoagulants in patients with atrial fibrillation and their associations with stroke risk","volume":"7","author":"Komen","year":"2021","journal-title":"Eur Heart J Cardiovasc Pharmacother"},{"key":"2025030423483480300_euaf027-B52","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1093\/europace\/euac062","article-title":"Early diagnosis and better rhythm management to improve outcomes in patients with atrial fibrillation: the 8th AFNET\/EHRA consensus conference","volume":"25","author":"Schnabel","year":"2023","journal-title":"Europace"},{"key":"2025030423483480300_euaf027-B53","doi-asserted-by":"crossref","first-page":"euad226","DOI":"10.1093\/europace\/euad226","article-title":"Atrial fibrillation and stroke prevention: 25 years of research at EP Europace journal","volume":"25","author":"Lip","year":"2023","journal-title":"Europace"},{"key":"2025030423483480300_euaf027-B54","doi-asserted-by":"crossref","first-page":"2381","DOI":"10.1016\/j.jacc.2018.03.003","article-title":"Smartwatch algorithm for automated detection of atrial fibrillation","volume":"71","author":"Bumgarner","year":"2018","journal-title":"J Am Coll Cardiol"},{"key":"2025030423483480300_euaf027-B55","doi-asserted-by":"crossref","first-page":"2365","DOI":"10.1016\/j.jacc.2019.08.019","article-title":"Mobile photoplethysmographic technology to detect atrial fibrillation","volume":"74","author":"Guo","year":"2019","journal-title":"J Am Coll Cardiol"}],"container-title":["Europace"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/europace\/advance-article-pdf\/doi\/10.1093\/europace\/euaf027\/61870651\/euaf027.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/europace\/article-pdf\/27\/2\/euaf027\/61870651\/euaf027.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/europace\/article-pdf\/27\/2\/euaf027\/61870651\/euaf027.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,4]],"date-time":"2025-03-04T18:51:23Z","timestamp":1741114283000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/europace\/article\/doi\/10.1093\/europace\/euaf027\/8011532"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2]]},"references-count":55,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,2,5]]}},"URL":"https:\/\/doi.org\/10.1093\/europace\/euaf027","relation":{},"ISSN":["1099-5129","1532-2092"],"issn-type":[{"value":"1099-5129","type":"print"},{"value":"1532-2092","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025,2]]},"published":{"date-parts":[[2025,2]]},"article-number":"euaf027"}}